SAN DIEGO, Oct. 23, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a global leader in in vitro diagnostics, has ...
This study explores the therapeutic potential of Mazindol ER, a triple monoamine reuptake inhibitor with additional activity on 5-HT1A, MOP, and OX2R receptors, for fentanyl dependence. Preclinical ...
New platform empowers healthcare organizations to transform laboratory metrics into actionable insights for better patient care. CHICAGO, Sept. 26, 2025 /PRNewswire/ -- The American Society for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback